Artificial intelligence and deep learning in ophthalmology

Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied t...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting, Daniel Shu Wei, Pasquale, Louis R., Peng, Lily, Campbell, John Peter, Lee, Aaron Y., Raman, Rajiv, Tan, Gavin Siew Wei, Schmetterer, Leopold, Keane, Pearse A., Wong, Tien Yin
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/10356/145320
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-145320
record_format dspace
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Glaucoma
Imaging
spellingShingle Science::Medicine
Glaucoma
Imaging
Ting, Daniel Shu Wei
Pasquale, Louis R.
Peng, Lily
Campbell, John Peter
Lee, Aaron Y.
Raman, Rajiv
Tan, Gavin Siew Wei
Schmetterer, Leopold
Keane, Pearse A.
Wong, Tien Yin
Artificial intelligence and deep learning in ophthalmology
description Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied to fundus photographs, optical coherence tomography and visual fields, achieving robust classification performance in the detection of diabetic retinopathy and retinopathy of prematurity, the glaucoma-like disc, macular oedema and age-related macular degeneration. DL in ocular imaging may be used in conjunction with telemedicine as a possible solution to screen, diagnose and monitor major eye diseases for patients in primary care and community settings. Nonetheless, there are also potential challenges with DL application in ophthalmology, including clinical and technical challenges, explainability of the algorithm results, medicolegal issues, and physician and patient acceptance of the AI 'black-box' algorithms. DL could potentially revolutionise how ophthalmology is practised in the future. This review provides a summary of the state-of-the-art DL systems described for ophthalmic applications, potential challenges in clinical deployment and the path forward.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Ting, Daniel Shu Wei
Pasquale, Louis R.
Peng, Lily
Campbell, John Peter
Lee, Aaron Y.
Raman, Rajiv
Tan, Gavin Siew Wei
Schmetterer, Leopold
Keane, Pearse A.
Wong, Tien Yin
format Article
author Ting, Daniel Shu Wei
Pasquale, Louis R.
Peng, Lily
Campbell, John Peter
Lee, Aaron Y.
Raman, Rajiv
Tan, Gavin Siew Wei
Schmetterer, Leopold
Keane, Pearse A.
Wong, Tien Yin
author_sort Ting, Daniel Shu Wei
title Artificial intelligence and deep learning in ophthalmology
title_short Artificial intelligence and deep learning in ophthalmology
title_full Artificial intelligence and deep learning in ophthalmology
title_fullStr Artificial intelligence and deep learning in ophthalmology
title_full_unstemmed Artificial intelligence and deep learning in ophthalmology
title_sort artificial intelligence and deep learning in ophthalmology
publishDate 2020
url https://hdl.handle.net/10356/145320
_version_ 1759854544621142016
spelling sg-ntu-dr.10356-1453202023-03-05T16:43:04Z Artificial intelligence and deep learning in ophthalmology Ting, Daniel Shu Wei Pasquale, Louis R. Peng, Lily Campbell, John Peter Lee, Aaron Y. Raman, Rajiv Tan, Gavin Siew Wei Schmetterer, Leopold Keane, Pearse A. Wong, Tien Yin Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine Glaucoma Imaging Artificial intelligence (AI) based on deep learning (DL) has sparked tremendous global interest in recent years. DL has been widely adopted in image recognition, speech recognition and natural language processing, but is only beginning to impact on healthcare. In ophthalmology, DL has been applied to fundus photographs, optical coherence tomography and visual fields, achieving robust classification performance in the detection of diabetic retinopathy and retinopathy of prematurity, the glaucoma-like disc, macular oedema and age-related macular degeneration. DL in ocular imaging may be used in conjunction with telemedicine as a possible solution to screen, diagnose and monitor major eye diseases for patients in primary care and community settings. Nonetheless, there are also potential challenges with DL application in ophthalmology, including clinical and technical challenges, explainability of the algorithm results, medicolegal issues, and physician and patient acceptance of the AI 'black-box' algorithms. DL could potentially revolutionise how ophthalmology is practised in the future. This review provides a summary of the state-of-the-art DL systems described for ophthalmic applications, potential challenges in clinical deployment and the path forward. Ministry of Health (MOH) National Medical Research Council (NMRC) Published version This project received funding from the National Medical Research Council (NMRC), Ministry of Health (MOH), Singapore National Health Innovation Center, Innovation to Develop Grant (NHIC-I2D-1409022), SingHealth Foundation Research Grant (SHF/FG648S/2015), and the Tanoto Foundation, and unrestricted donations to the Retina Division, Johns Hopkins University School of Medicine. For the Singapore Epidemiology of Eye Diseases (SEED) study, we received funding from NMRC, MOH (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and STaR/2013; CG/SERI/2010) and Biomedical Research Council (grants 08/1/35/19/550 and 09/1/35/19/616). The Singapore Integrated Diabetic Retinopathy Programme (SiDRP) received funding from the MOH, Singapore (grants AIC/RPDD/SIDRP/SERI/FY2013/0018 and AIC/HPD/FY2016/0912). In USA, it is supported by the National Institutes of Health (K12 EY027720, R01EY019474, P30EY10572, P41EB015896), by the National Science Foundation (SCH-1622542, SCH-1622536, SCH-1622679) and by unrestricted departmental funding from Research to Prevent Blindness. PAK is supported by a UK National Institute for Health Research (NIHR) Clinician Scientist Award (NIHR-CS--2014-12-023). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. 2020-12-17T04:27:28Z 2020-12-17T04:27:28Z 2018 Journal Article Ting, D. S. W., Pasquale, L. R., Peng, L., Campbell, J. P., Lee, A. Y., Raman, R., . . . Wong, T. Y. (2018). Artificial intelligence and deep learning in ophthalmology. British Journal of Ophthalmology, 103(2), 167–175. doi:10.1136/bjophthalmol-2018-313173 0007-1161 https://hdl.handle.net/10356/145320 10.1136/bjophthalmol-2018-313173 30361278 2 103 167 175 en NHIC-I2D-1409022 SHF/FG648S/2015 0796/2003 IRG07nov013 IRG09nov014 STaR/0003/2008 STaR/2013; CG/SERI/2010 08/1/35/19/550 09/1/35/19/616 IC/RPDD/SIDRP/SERI/FY2013/0018 AIC/HPD/FY2016/0912 The British journal of ophthalmology © 2019 Author(s) (or their employer(s)). Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0 application/pdf